Application 212871
- Type
- ANDA
- Sponsor
- ASPEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212871-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212871-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | 3bdfa0b2c4d7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212871-001 | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE / INJECTION | AP | 2022-11-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212871-001 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A212871-001 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A212871-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212871-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212871-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212871-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212871-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212871-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212871-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212871-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212871-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212871-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212871-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A212871-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212871-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212871-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212871-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A212871-001 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212871-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A212871-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A212871-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A212871-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A212871-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A212871-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A212871-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A212871-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A212871-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212871-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 987ba524-361e-49c3-9e00-550a78748542 | 2026-11-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | d93a9b2b-708d-4db5-8aae-45fd3a7ca65c | 2026-11-05 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | fcb295e4-038f-4d4f-8786-4fbcd1d3c298 | 2026-11-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 74d51ba3-0ca0-4a04-aa87-1c243f885bd8 | 2026-11-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2026-10-30 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 48a8356e-377e-45ef-a1bf-e9ffec051749 | 2026-10-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 83602e34-7a8c-4606-b43e-23ab909b6c1a | 2026-10-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-10-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE | Granules Pharmaceuticals Inc. | 0f05c5d3-9c41-4dae-88d1-18cbddc69487 | 2026-10-08 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 5d7a742e-2bcf-4db4-a07c-f669938e4068 | 2026-09-16 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | 62e1ba35-bc84-4818-be54-8b534a1bf93c | 2026-09-10 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | f7187ddb-ea11-4aa8-8215-a5fcf0f1ca7c | 2026-09-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2026-09-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 2972f22e-378c-450b-8869-1354a9bd0ffc | 2026-07-23 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2026-07-23 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | 1f266d77-4f9e-44c9-a000-2f8fea3ac80b | 2026-07-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2026-07-07 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 220cd5f5-3d71-4fdb-9943-7468799c179f | 2026-06-02 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |
| 25021-789 | Glycopyrrolate | Glycopyrrolate | Sagent Pharmaceuticals | ANDA | Current |